NGN CAPITAL
NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector. The fund focuses specifically on investments in the healthcare, pharmaceutical, and biotech sectors including drug products, medical devices, diagnostics, and healthcare services.
NGN CAPITAL
Industry:
Biotechnology Pharmaceutical Venture Capital
Founded:
2003-07-01
Status:
Active
Contact:
+1 212 972 0077
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta Google Font API LetsEncrypt Content Delivery Network Organization Schema Typekit LocalBusiness Schema Squarespace
Similar Organizations
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
SnowMark Corporation
SnowMark Corporation is a venture capital firm specializing in investments in technology, healthcare informatics, and real estate sectors.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-07-24 | Exosome Diagnostics | NGN Capital investment in Series C - Exosome Diagnostics | 30 M USD |
| 2016-01-07 | Exosome Diagnostics | NGN Capital investment in Series B - Exosome Diagnostics | 16 M USD |
| 2015-09-02 | Exosome Diagnostics | NGN Capital investment in Series B - Exosome Diagnostics | 17.6 M USD |
| 2014-03-11 | Exosome Diagnostics | NGN Capital investment in Series B - Exosome Diagnostics | 27 M USD |
| 2014-01-01 | PIN Pharma | NGN Capital investment in Series A - PIN Pharma | 6.75 M USD |
| 2013-11-27 | Endosense | NGN Capital investment in Series C - Endosense | 37.4 M CHF |
| 2012-11-27 | Endosense | NGN Capital investment in Series C - Endosense | 40.3 M USD |
| 2012-07-23 | Cerapedics | NGN Capital investment in Series C - Cerapedics | 19 M USD |
| 2010-12-17 | Small Bone Innovations | NGN Capital investment in Series F - Small Bone Innovations | 15 M USD |
| 2010-07-20 | Artisan Pharma | NGN Capital investment in Series C - Artisan Pharma | 3 M USD |